1. Beth Israel Deaconess Medical Center

    0 Comments Leave a Comment

    1-15 of 27 1 2 »
    1. Mentioned In 27 Articles

    2. Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus eluting bioresorbable polylactide scaffold in comparison with the cobalt chromium metallic stent?

      Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus eluting bioresorbable polylactide scaffold in comparison with the cobalt chromium metallic stent?
      Aims: Immediately after stent/scaffold implantation, quantitative coronary angiography (QCA) with respect to optical coherence tomography (OCT) more severely underestimates the lumen diameter (LD) in Absorb than in XIENCE. This OCT-QCA discrepancy has not been evaluated at long-term follow-up. The present study aimed to assess the accuracy of QCA with reference to OCT in Absorb as compared to XIENCE.
      Read Full Article
    3. Beth Isreal Deaconess Medical Center Receives Grant for Intravascular Molecular-Structural Imaging of Coronary Stent Pathobiology

      Beth Isreal Deaconess Medical Center Receives Grant for Intravascular Molecular-Structural Imaging of Coronary Stent Pathobiology
      ...of the propose work.

      Dr. Eric Osborn is an early career faculty member at Beth Israel Deaconess Medical Center (BIDMC) and Massachusetts General Hospital (MGH), and an Instructor in Me...

      Read Full Article
    4. Collar Sign in Incompletely Occluded Aneurysms after Pipeline Embolization: Evaluation with Angiography and Optical Coherence Tomography

      Collar Sign in Incompletely Occluded Aneurysms after Pipeline Embolization: Evaluation with Angiography and Optical Coherence Tomography
      BACKGROUND AND PURPOSE: Flow diversion with the Pipeline Embolization Device has emerged as an attractive treatment for cerebral aneurysms. Processes involved in aneurysm occlusion include changes in intra-aneurysmal hemodynamics and endothelialization of the device. Here, we call attention to a radiographic sign not previously reported that is detected in incompletely occluded aneurysms after treatment with the Pipeline Embolization Device at angiographic follow-up and referred to as the collar sign. MATERIALS ...
      Read Full Article
    5. Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis

      Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis
      Objectives This study sought to determine whether indocyanine green (ICG)enhanced near-infrared fluorescence (NIRF) imaging can illuminate high-risk histologic plaque features of human carotid atherosclerosis, and in coronary atheroma of living swine, using intravascular NIRF-optical coherence tomography (OCT) imaging. Background New translatable imaging approaches are needed to identify high-risk biological signatures of atheroma. ICG is a U.S. Food and Drug Administrationapproved NIRF imaging agent that experimentally targets plaque macrophages ...
      Read Full Article
    6. The new kid on the block for advanced imaging in Barrett’s esophagus: a review of volumetric laser endomicroscopy

      The new kid on the block for advanced imaging in Barrett’s esophagus: a review of volumetric laser endomicroscopy
      Advanced imaging techniques used in the management of Barretts esophagus include electronic imaging enhancement (e.g. narrow band imaging, flexible spectral imaging color enhancement, and i-Scan), chromoendoscopy, and confocal laser endomicroscopy. Electronic imaging enhancement is used frequently in daily practice, but use of the other advanced technologies is not routine. High-definition white light endoscopy and random four quadrant biopsy remain the standard of care for evaluation of Barretts esophagus; this ...
      Read Full Article
    7. NinePoint Medical Announces FDA 510(k) Clearance of a Real-Time Targeting Feature for the NvisionVLE® Imaging System and the First Clinical Cases in the U.S.

      NinePoint Medical Announces FDA 510(k) Clearance of a Real-Time Targeting Feature for the NvisionVLE® Imaging System and the First Clinical Cases in the U.S.
      ...come an integral part of the care of my patients with esophageal disease,” stated Dr. Douglas K. Pleskow, MD, Beth Israel Deaconess Medical Center, Associate Clinical Professor of Medicine, Harvard Medical School. “The a...
      Read Full Article
    8. Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging

      Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging
      ...e Netherlands Department of Biomedical Engineering, Boston University, Boston, MA, USA Cardiology Division, Beth Israel Deaconess Medical Center, Boston, MA, USA Department of Pathology, Harvard Medical School and Mas...
      Read Full Article
    9. Massachusetts Institute of Technology receives a 2012 NIH Grant for Optical Biopsy Using Optical Coherence Tomography

      Massachusetts Institute of Technology receives a 2012 NIH Grant  for Optical Biopsy Using Optical Coherence Tomography
      ...linical studies in a collaborative effort between investigators at the Massachusetts Institute of Technology, Beth Israel Deaconess Medical Center, Boston VA Healthcare System, and Harvard Medical School. The specific ai...
      Read Full Article
    10. Integrated Optical Coherence Tomography and Optical Coherence Microscopy Imaging of Ex Vivo Human Renal Tissues

      Integrated Optical Coherence Tomography and Optical Coherence Microscopy Imaging of Ex Vivo Human Renal Tissues
      ... Harvard Medical School, Boston, Massachusetts , * Amy E. Mondelblatt Affiliations + Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts , * Yihong Wang Affiliatio...
      Read Full Article
    11. MIT Receives NIH Grant for Research on Wavefront Corrected Multimodal Optical Coherence and Two-Photon Microscopy

      MIT Receives NIH Grant for Research on Wavefront Corrected Multimodal Optical Coherence and Two-Photon Microscopy
      ...is Yuankai Tao, and the project is co-sponsored by Prof. James G. Fujimoto (MIT) and Prof. James L. Connolly (Beth Israel Deaconess Medical Center/Harvard Medical School). A brief description of the project is given belo...
      Read Full Article
    12. MIT Wins NIH Grant for Developing Optical Biopsy Technology Using Optical Coherence Tomography

      MIT Wins NIH Grant for Developing Optical Biopsy Technology Using Optical Coherence Tomography
      ...linical studies in a collaborative effort between investigators at the Massachusetts Institute of Technology, Beth Israel Deaconess Medical Center, Boston VA Healthcare System, and Harvard Medical School. The specific ai...
      Read Full Article
    13. MIT Receives NIH Award for Integrated Optical Coherence Tomography and Microscopy for Molecular-Targeted Imaging

      MIT Receives NIH Award for Integrated Optical Coherence Tomography and Microscopy for Molecular-Targeted Imaging
      ...l authority on OCT technologies at MIT; Dr. John V. Frangioni, a distinguished leader in molecular imaging at Beth Israel Deaconess Medical Center (BIDMC) and the Harvard Medical School (HMS); and Dr. James L. Connolly, ...
      Read Full Article
    14. 1-15 of 27 1 2 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Beth Israel Deaconess Medical Center

    Beth Israel Deaconess Medical Center

    Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a major teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center is the third-largest recipient of biomedical research funding from the National Institutes of Health.